Aggregator

In a rebuke to President Trump, the Democrats flipped both the Senate and the House.

Voters blamed tariffs and the Iran war for their affordability problems

The magnitude of the Democrats' outcome was always a possibility, but the depth and breadth of their victories were jaw-dropping.

US voters handed Democrats control of Congress in midterm elections on Tuesday, delivering a stunning repudiation of President Donald Trump.

The Bloomberg Tech event looked ahead to new balance of power in US

On October 29, 2026, BioAdaptives, Inc. entered into a definitive Membership Interest Purchase Agreement to acquire 100% of the issued and outstanding membership interests of Xycota Biosciences LLC, a preclinical biotechnology company developing central-nervous-system product can

Autohome Inc. announced its unaudited financial results for the third quarter ended September 30, 2026. Net revenues for the quarter were RMB1,315.0 million (US$196.1 million), down from RMB1,778.1 million in the corresponding period of 2025. Net income attributable to Autohome w

President Donald Trump discusses the possibility of renewed military action against Iran, saying he remains open to a binding agreement preventing Tehran from obtaining nuclear weapons but warning he could 'finish the job' if negotiations fail.

Avient Corporation announced its third quarter 2026 financial results, reporting sales growth of 10.5% to $891 million compared to the prior year quarter, driven by strong sales growth in both business segments. Third quarter GAAP earnings per share (EPS) rose to $0.46 from $0.36

In recent trading, shares of CONMED Corp (Symbol: CNMD) have crossed above the average analyst 12-month target price of $47.00, changing hands for $47.23/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuatio

In recent trading, shares of CONMED Corp (Symbol: CNMD) have crossed above the average analyst 12-month target price of $47.00, changing hands for $47.23/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuatio

In recent trading, shares of CONMED Corp (Symbol: CNMD) have crossed above the average analyst 12-month target price of $47.00, changing hands for $47.23/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuatio

In recent trading, shares of Rollins, Inc. (Symbol: ROL) have crossed above the average analyst 12-month target price of $36.12, changing hands for $37.35/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati

In recent trading, shares of Rollins, Inc. (Symbol: ROL) have crossed above the average analyst 12-month target price of $36.12, changing hands for $37.35/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati

In recent trading, shares of Rollins, Inc. (Symbol: ROL) have crossed above the average analyst 12-month target price of $36.12, changing hands for $37.35/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati

House Democrats will see a slew of new far-left lawmakers enter their ranks next year after Tuesday night's midterm elections.

House Democrats will see a slew of new far-left lawmakers enter their ranks next year after Tuesday night's midterm elections.

Republicans face hard midterm election lessons on candidate quality, primary elections and endorsements as House and Senate leadership changes loom.

Republicans face hard midterm election lessons on candidate quality, primary elections and endorsements as House and Senate leadership changes loom.